Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

A Randomized, Double-Blind, Placebo-Controlled, Parallel-Group Study of ISB 830 in Adult Subjects With Moderate to Severe Atopic Dermatitis.

NCT03568162 is registered in ClinicalTrials.gov with Ichnos Sciences SA as lead sponsor.

NCT NCT03568162
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT03568162 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
A Randomized, Double-Blind, Placebo-Controlled, Parallel-Group Study of ISB 830 in Adult Subjects With Moderate to Severe Atopic Dermatitis.
Lead sponsor
Ichnos Sciences SA
Phase
Phase 2
Overall status
Completed
Start date
May 31, 2018
Completion date
August 3, 2021
Enrollment
462 (actual)
Sites
83

Conditions

As the registry lists them; a condition with its own page is linked.

moderate to severe atopic dermatitis